Desuden bør Udvalget for Avancerede Terapier høres i forbindelse med vurdering af andre lægemidler, der kræver særlig sagkundskab inden for udvalgets kompetenceområde.
In addition, the Committee for Advanced Therapies should be consulted for the evaluation of any other medicinal product which requires specific expertise falling within its area of competence.